A new oral contraceptive regimen for endometriosis management: preliminary experience with 24/4-day drospirenone/ethinilestradiol 3 mg/20 mcg

References

• Vercellini P, Somigliana E, Viganò P, Abbiati A, Daguati R, Crosignani PG. Endometriosis: Current and future medical therapies. Best Pract Res Clin Obstet Gynaecol 2008;22:275–306.
   PubMed Web of Science ®Google Scholar
• Seracchioli R, Mabrouk M, Manuzzi L, Vicenzi C, Frascà C, Elmakky A, Venturoli S. Post-operative use of oral contraceptive pills for prevention of anatomical relapse or symptom-recurrence after conservative surgery for endometriosis. Hum Reprod 2009;24:2729–2735.
   PubMed Web of Science ®Google Scholar
• Davis LJ, Kennedy SS, Moore J, Prentice A. Modern combined oral contraceptives for pain with endometriosis. Cochrane Database Syst Rev 2007;18: CD001019.
   Google Scholar
• Seracchioli R, Mabrouk M, Frascà C, Manuzzi L, Montanari G, Keramyda A, Venturoli S. Long-term cyclic and continuous oral contraceptive therapy and endometrioma recurrence: A randomized controlled trial. Fertil Steril 2010;93:52–56.
   PubMed Web of Science ®Google Scholar
• Vercellini P, Crosignani P, Somigliana E, Viganò P, Frattaruolo MP, Fedele L. ‘Waiting for Godot’: A commonsense approach to the medical treatment of endometriosis. Hum Reprod 2011;26:3–13.
   PubMed Web of Science ®Google Scholar
• Vercellini P, Frontino G, De Giorgi O, Pietropaolo G, Pasin R, Crosignani PG. Continuous use of an oral contraceptive for endometriosis-associated recurrent dysmenorrhea that does not respond to a cyclic pill regimen. Fertil Steril 2003;80:560–563.
   PubMed Web of Science ®Google Scholar
• Sulak PJ. Continuous oral contraception: changing times. Best Pract Res Clin Obstet Gynaecol 2008;22:355–374.
   PubMed Web of Science ®Google Scholar
• Bachmann G, Sulak PJ, Sampson-Landers C, Benda N, Marr J. Efficacy and safety of a low-dose 24-day combined oral contraceptive containing 20 micrograms ethinylestradiol and 3 mg drospirenone. Contraception 2004;70:191–198.
   PubMed Web of Science ®Google Scholar
• Hernádi L, Marr J, Trummer D, De Leo V, Petraglia F. Efficacy and safety of a low-dose combined oral contraceptive containing drospirenone 3 mg and ethinylestradiol 20 mcg in a 24/4-day regimen. Contraception 2009;80:18–24.
   PubMed Web of Science ®Google Scholar
• Anttila L, Kunz M, Marr J. Bleeding pattern with drospirenone 3 mg + ethinyl estradiol 20 mcg 24/4 combined oral contraceptive compared with desogestrel 150 mcg + ethinyl estradiol 20 mcg 21/7 combined oral contraceptive. Contraception 2009;80:445–451.
   PubMed Web of Science ®Google Scholar
• Coffee AL, Sulak PJ, Kuehl TJ. Long-term assessment of symptomatology and satisfaction of an extended oral contraceptive regimen. Contraception 2007;75:444–449.
   PubMed Web of Science ®Google Scholar
• Yonkers KA, Brown C, Pearlstein TB, Foegh M, Sampson-Landers C, Rapkin A. Efficacy of a new low-dose oral contraceptive with drospirenone in premenstrual dysphoric disorder. Obstet Gynecol 2005;106:492–501.
   PubMed Web of Science ®Google Scholar
• Fenton C, Wellington K, Moen MD, Robinson DM. Drospirenone/ethinylestradiol 3 mg/20 mcg (24/4 day regimen): A review of its use in contraception, premenstrual dysphoric disorder and moderate acne vulgaris. Drugs 2007;67:1748–1765.
   Web of Science ®Google Scholar
• Klipping C, Duijkers I, Trummer D, Marr J. Suppression of ovarian activity with a drospirenone-containing oral contraceptive in a 24/4 regimen. Contraception 2008;78:16–25.
   PubMed Web of Science ®Google Scholar
• Huskisson EE. Visual analogue scales. Pain measurement and assessement. New York: Raven Press; 1983. pp. 33–37.
   Google Scholar
• Seracchioli R, Mabrouk M, Frascà C, Manuzzi L, Savelli L, Venturoli S. Long-term oral contraceptive pills and postoperative pain management after laparoscopic excision of ovarian endometrioma: A randomized controlled trial. Fertil Steril 2010;94:464–471.
   PubMed Web of Science ®Google Scholar
• Van Holsbeke C, Van Calster B, Guerriero S, Savelli L, Paladini D, Lissoni AA, Czekierdowski A, et al. Endometriomas: Their ultrasound characteristics. Ultrasound Obstet Gynecol 2010;35:730–740.
   PubMed Web of Science ®Google Scholar
• Exacoustos C, Zupi E, Carusotti C, Rinaldo D, Marconi D, Lanzi G, Arduini D. Staging of pelvic endometriosis: Role of sonographic appearance in determining extension of disease and modulating surgical approach. J Am Assoc Gynecol Laparosc 2003;10:378–382.
   PubMedGoogle Scholar
• Savelli L. Transvaginal sonography for the assessment of ovarian and pelvic endometriosis: How deep is our understanding? Ultrasound Obstet Gynecol 2009;33:497–501.
   PubMed Web of Science ®Google Scholar
• Kamencic H, Thiel JA. Pentoxifylline after conservative surgery for endometriosis: A randomized, controlled trial. J Minim Invasive Gynecol 2008;15:62–66.
   PubMed Web of Science ®Google Scholar
• Harada T, Momoeda M, Taketani Y, Hoshiai H, Terakawa N. Low-dose oral contraceptive pill for dysmenorrhea associated with endometriosis: A placebo-controlled, double-blind, randomized trial. Fertil Steril 2008;90:1583–1588.
   PubMed Web of Science ®Google Scholar
• Vercellini P, De Giorgi O, Mosconi P, Stellato G, Vicentini S, Crosignani PG. Cyproterone acetate versus a continuous monophasic oral contraceptive in the treatment of recurrent pelvic pain after conservative surgery for symptomatic endometriosis. Fertil Steril 2002;77:52–61.
   PubMed Web of Science ®Google Scholar
• Vercellini P, Pietropaolo G, De Giorgi O, Pasin R, Chiodini A, Crosignani PG. Treatment of symptomatic rectovaginal endometriosis with an estrogen-progestogen combination versus low-dose norethindrone acetate. Fertil Steril 2005;84:1375–1387.
   PubMed Web of Science ®Google Scholar
• Rodgers AK, Falcone T. Treatment strategies for endometriosis. Expert Opin Pharmacother 2008;9:243–255.
   PubMed Web of Science ®Google Scholar
• Crosignani P, Olive D, Bergqvist A, Luciano A. Advances in the management of endometriosis: An update for clinicians. Hum Reprod Update 2006;12:179–189.
   PubMed Web of Science ®Google Scholar
• Fauconnier A, Chapron C. Endometriosis and pelvic pain: Epidemiological evidence of the relationship and implications. Hum Reprod Update 2005;11:595–606.
   PubMed Web of Science ®Google Scholar
• Meresman GF, Augé L, Barañao RI, Lombardi E, Tesone M, Sueldo C. Oral contraceptives suppress cell proliferation and enhance apoptosis of eutopic endometrial tissue from patients with endometriosis. Fertil Steril 2002;77:1141–1147.
   PubMed Web of Science ®Google Scholar
• Howard FM. Endometriosis and mechanisms of pelvic pain. J Minim Invasive Gynecol 2009;16:540–550.
   PubMed Web of Science ®Google Scholar
• Muzii L, Marana R, Caruana P, Catalano GF, Margutti F, Panici PB. Postoperative administration of monophasic combined oral contraceptives after laparoscopic treatment of ovarian endometriomas: A prospective, randomized trial. Am J Obstet Gynecol 2000;183:588–592.
   PubMed Web of Science ®Google Scholar